Pharmaceutical Bottles

Traditional and cost-effective dosage method

Pharmaceutical bottles are cost-effective traditional dosage forms, available in glass or plastic containers. Those glass and plastic bottles are particularly recommended for products with adapted dosage, varying according to body weight.

Unither's Rochester site specializing in the development and manufacturing of pharmaceutical bottles. These are suitable for storage of solutions and suspensions for oral use, including formulations with controlled and sustained release.

Specificities

Filling (all sites): 20 to 500mL
Filling (Rochester site): 15 to 473mL
Glass or plastic container (PET, HDPE, …).

PET plastic is 100% recyclable and in principle does not lose its fundamental characteristics and can therefore be reused repeatedly. PET plastic is often used for the production of oral liquid solutions.

HDPE plastic is opaque, impact resistant, impervious to water, certain chemicals, gases and aromas

Formulations with or without sugar and/or preservatives
Specific know-how regarding the manufacture of:
– light-sensitive products
– plant extracts products
– products with a high alcohol content (> 30 %)
Pilot equipment for small batches (tech-transfer and clinical batches)
Analytical R&D and quality control laboratories for method development and validation, ICH stability studies, quality control and release, regulatory expertise to answer to pharmaceutical requirements.

Advantages of pharmaceutical bottles

Products with adapted dosage thanks to the addition of devices – measuring spoon, pipette, measuring cup, making it possible to administer doses based on the weight of babies or children, amongst other things
Children’s safety guaranteed by products developed according to a specific packaging and design with adapted caps: child proof resistant
Various forms, sizes and colours
Ideal products for oral administration of syrups, solutions and suspensions or for topical applications

Authorizations

The Rochester site is inspected by the FDA (Food Drug and Administration), DEA certificate, as well as: Turkish Ministry of Health, MHA (Mexico City), ANVISA (Brazilian agency) EMA (European agency), MHRA (UK) and “Health Canada“, etc.

Our company CDMO Unither Pharma has three bottling sites: one in France, Brazil and one in the United States. The French site is often inspected by the the French authorities (ANSM), allowing the products to be sold on the European market. The Brazilian site is controlled by ANVISA.

Manufacturing plants and capacity

Total capacity: 100 million bottles/year

Rochester, NY USA

Colomiers, France

Barretos, Brazil